Monthly Archives

December 2019

ASH and FDA Unveil New Recommendations to Guide Clinical Development of Sickle Cell Disease Therapies

  • December 13, 2019
  • Burrell Jacqueline

Joint FDA/ASH Led Initiative Highlights Importance of Using Patient Reported Outcomes and Biomarkers in Clinical Trials to Advance SCD Therapies (WASHINGTON,... Continue Reading

GBT’s Oxbryta™ (voxelotor) tablets is approved for the treatment of sickle cell disease

  • December 3, 2019
  • Burrell Jacqueline

Oxbryta™ (voxelotor) tablets Now Approved On behalf of GBT, we are happy to share that Oxbryta (pronounced ox-brye-ta) is now approved... Continue Reading

New Hope for a Sickle Cell Cure

  • December 2, 2019
  • Burrell Jacqueline

How gene therapy is helping children with this devastating disease. By Joy Harrington, Writer When Mr. and Mrs. Jones married and left... Continue Reading



				
Powered by DoJiggy Nonprofit Website Hosting
productionded9